Literature DB >> 21084859

CaV1.3 as pacemaker channels in adrenal chromaffin cells: specific role on exo- and endocytosis?

Valentina Comunanza1, Andrea Marcantoni, David H Vandael, Satyajit Mahapatra, Daniela Gavello, Valentina Carabelli, Emilio Carbone.   

Abstract

Voltage-gated L-type calcium channels (LTCCs) are expressed in adrenal chromaffin cells. Besides shaping the action potential (AP), LTCCs are involved in the excitation-secretion coupling controlling catecholamine release and in Ca (2+) -dependent vesicle retrieval. Of the two LTCCs expressed in chromaffin cells (CaV1.2 and CaV1.3), CaV1.3 possesses the prerequisites for pacemaking spontaneously firing cells: low-threshold, steep voltage-dependence of activation and slow inactivation. By using CaV1 .3 (-/-) KO mice and the AP-clamp it has been possible to resolve the time course of CaV1.3 pacemaker currents, which is similar to that regulating substantia nigra dopaminergic neurons. In mouse chromaffin cells CaV1.3 is coupled to fast-inactivating BK channels within membrane nanodomains and controls AP repolarization. The ability to carry subthreshold Ca (2+) currents and activate BK channels confers to CaV1.3 the unique feature of driving Ca (2+) loading during long interspike intervals and, possibly, to control the Ca (2+) -dependent exocytosis and endocytosis processes that regulate catecholamine secretion and vesicle recycling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084859     DOI: 10.4161/chan.4.6.12866

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  12 in total

Review 1.  Roles of Na+, Ca2+, and K+ channels in the generation of repetitive firing and rhythmic bursting in adrenal chromaffin cells.

Authors:  Christopher J Lingle; Pedro L Martinez-Espinosa; Laura Guarina; Emilio Carbone
Journal:  Pflugers Arch       Date:  2017-08-03       Impact factor: 3.657

Review 2.  Trafficking and stability of voltage-gated calcium channels.

Authors:  Brett A Simms; Gerald W Zamponi
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

Review 3.  Regulation by L-type calcium channels of endocytosis: an overview.

Authors:  Juliana M Rosa; Carmen Nanclares; Angela Orozco; Inés Colmena; Ricardo de Pascual; Antonio G García; Luis Gandía
Journal:  J Mol Neurosci       Date:  2012-05-12       Impact factor: 3.444

4.  Are Ca(v)1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blockers usage.

Authors:  Satyajit Mahapatra; Andrea Marcantoni; David H Vandael; Jörg Striessnig; Emilio Carbone
Journal:  Channels (Austin)       Date:  2011-05-01       Impact factor: 2.581

Review 5.  Signaling complexes of voltage-gated calcium channels.

Authors:  Ray W Turner; Dustin Anderson; Gerald W Zamponi
Journal:  Channels (Austin)       Date:  2011-09-01       Impact factor: 2.581

Review 6.  T-type channel-mediated neurotransmitter release.

Authors:  Emilio Carbone; Chiara Calorio; David H F Vandael
Journal:  Pflugers Arch       Date:  2014-03-06       Impact factor: 3.657

Review 7.  L-type calcium channels in exocytosis and endocytosis of chromaffin cells.

Authors:  Carmen Nanclares; Andrés M Baraibar; Luis Gandía
Journal:  Pflugers Arch       Date:  2017-09-02       Impact factor: 3.657

Review 8.  Leptin-mediated ion channel regulation: PI3K pathways, physiological role, and therapeutic potential.

Authors:  Daniela Gavello; Emilio Carbone; Valentina Carabelli
Journal:  Channels (Austin)       Date:  2016-03-28       Impact factor: 2.581

9.  Distinct patterns of exocytosis elicited by Ca2+, Sr2+ and Ba2+ in bovine chromaffin cells.

Authors:  Andrés M Baraibar; Ricardo de Pascual; Marcial Camacho; Natalia Domínguez; J David Machado; Luis Gandía; Ricardo Borges
Journal:  Pflugers Arch       Date:  2018-06-21       Impact factor: 3.657

10.  The human L-type calcium channel Cav1.3 regulates insulin release and polymorphisms in CACNA1D associate with type 2 diabetes.

Authors:  T M Reinbothe; S Alkayyali; E Ahlqvist; T Tuomi; B Isomaa; V Lyssenko; E Renström
Journal:  Diabetologia       Date:  2012-11-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.